文献速递慢性肾脏病肾小球疾病

非甾体盐皮质激素受体阻断剂艾沙利酮减少肾小球高滤过与白蛋白尿

The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

本研究在醛固酮诱导的MR激活大鼠和2型糖尿病db/db小鼠中,用体内多光子成像评估单个肾单位肾小球滤过率(SNGFR)和微动脉直径,并在致密斑细胞中观察MR激活对管球反馈的影响。结果显示艾沙利酮可减轻醛固酮诱导的入球微动脉扩张所致肾小球高滤过,在db/db小鼠中降低SNGFR和尿白蛋白排泄并升高尿腺苷水平,该效应可被A1aR阻断逆转。作者认为艾沙利酮通过腺苷信号恢复管球反馈功能,从而减轻肾小球高滤过和白蛋白尿。

要点

  • 在醛固酮输注大鼠中,MR激活经入球微动脉扩张引起肾小球高滤过,艾沙利酮可减轻该效应。
  • 在db/db小鼠中,艾沙利酮降低SNGFR和尿白蛋白排泄,同时升高尿腺苷水平。
  • A1aR阻断可逆转艾沙利酮的上述效应,提示腺苷信号参与其作用机制。

核心结论

  • 作者认为艾沙利酮通过腺苷信号恢复管球反馈功能,从而减轻肾小球高滤过并减少白蛋白尿。

研究设计与样本

  • 研究使用醛固酮诱导的MR激活大鼠和2型糖尿病db/db小鼠,并以致密斑细胞进行机制观察。
  • 采用体内多光子成像评估单个肾单位肾小球滤过率(SNGFR)和微动脉直径。

主要发现

  • 在醛固酮输注大鼠中,MR激活经入球微动脉扩张引起肾小球高滤过,艾沙利酮可减轻该效应。
  • 在db/db小鼠中,艾沙利酮降低SNGFR和尿白蛋白排泄,同时升高尿腺苷水平,这些效应可被A1aR阻断逆转。
  • 在致密斑细胞中,MR激活增加一氧化氮(NO)产生并降低Na+-K+-2Cl-共转运体膜表达,MRA或神经元型一氧化氮合酶抑制均可减轻该效应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetic kidney disease (DKD) is a major cause of chronic kidney disease, with glomerular hyperfiltration contributing to its progression. Esaxerenone, a non-steroidal mineralocorticoid receptor antagonist (MRA), reduces albuminuria, but its precise mechanism remains unclear. Mineralocorticoid receptor (MR) activation is implicated in tubuloglomerular feedback (TGF) dysregulation, and we hypothesized that MR inhibition attenuates albuminuria by mitigating glomerular hyperfiltration. METHODS: To investigate the effects of esaxerenone, we used aldosterone-induced MR activation rats and type 2 diabetic (db/db) mice. In vivo multiphoton imaging was performed to assess the single-nephron glomerular filtration rate (SNGFR) and arteriolar diameters. Macula densa (MD) cells were used to examine MR activation's impact on TGF. RESULTS: In aldosterone-infused rats, MR activation induced glomerular hyperfiltration via afferent arteriolar dilation, which was attenuated by esaxerenone. In db/db mice, esaxerenone reduced SNGFR and urinary albumin excretion while increasing urinary adenosine levels, effects reversed by A1aR blockade. In MD cells, MR activation increased nitric oxide (NO) production and reduced Na+-K+-2Cl- cotransporter membrane expression, both of which were mitigated by MRA or neuronal nitric oxide synthase inhibition. CONCLUSION: These findings suggest that esaxerenone restores TGF function via adenosine signalling, attenuating glomerular hyperfiltration and reducing albuminuria. This study provides novel insights into the albuminuria-lowering effects of MR blockade in DKD and supports the therapeutic potential of esaxerenone.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Tatsugawa R, Kidokoro K, Iwakura T, et al. The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria. Nephrol Dial Transplant. 2026. PMID: 41206562. doi:10.1093/ndt/gfaf232

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。